Prostate adenocarcinoma
Showing 1 - 25 of 8,290
Prostate Adenocarcinoma Trial in Fuzhou (Personalized Optimization of Systematic Prostate Biopsy)
Recruiting
- Prostate Adenocarcinoma
- Personalized Optimization of Systematic Prostate Biopsy
-
Fuzhou, Fujian, ChinaDepartment of Urology, Fujian Union Hospital, Fujian Medical Uni
Aug 16, 2023
Adding MR Fusion to Standard US Guided Prostate Biopsy
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- TRUS biopsy
-
Tucson, ArizonaUniversity of Arizona
Jan 27, 2023
Prostate Adenocarcinoma Trial in Madrid (Prostate SBRT (stereotactic body radiation therapy) with focal boost)
Not yet recruiting
- Prostate Adenocarcinoma
- Prostate SBRT (stereotactic body radiation therapy) with focal boost
-
Madrid, SpainLa Princesa University Hospital, Health Research Institute, Madr
Jun 16, 2023
Prostate Adenocarcinoma Trial in Kansas City (Osanetant)
Recruiting
- Prostate Adenocarcinoma
-
Kansas City, KansasThe University of Kansas Cancer Center, Westwood Campus
Jan 3, 2023
Prospective Androgen Receptor Signaling Inhibitors Resistance
Not yet recruiting
- Prostate Cancer
- +3 more
- (no location specified)
Nov 15, 2023
Prostate Adenocarcinoma Trial in Duarte, Los Angeles, Durham (Fasting Mimicking Diet (FMD), Usual Diet)
Not yet recruiting
- Prostate Adenocarcinoma
- Fasting Mimicking Diet (FMD)
- Usual Diet
-
Duarte, California
- +2 more
Apr 27, 2023
dapted Strategy Including Magnetic Resonance Imaging and
Completed
- Prostate Cancer
- Prostate Adenocarcinoma
-
Ankara, TurkeyAnkara University School of Medicine
Sep 6, 2023
Prostate Adenocarcinoma Trial in Dallas (68-Ga PSMA11)
Not yet recruiting
- Prostate Adenocarcinoma
- 68-Ga PSMA11
-
Dallas, TexasUT Southwestern Medical Center
Sep 12, 2023
Prostate Adenocarcinoma Trial (De-escalated radiotherapy to be delivered on the Elekta Unity Unity MR-linac)
Not yet recruiting
- Prostate Adenocarcinoma
- De-escalated radiotherapy to be delivered on the Elekta Unity Unity MR-linac
- (no location specified)
Jan 23, 2023
Prostate Adenocarcinoma Trial in Kansas City (Osanetant)
Recruiting
- Prostate Adenocarcinoma
-
Kansas City, KansasThe University of Kansas Cancer Center, Westwood Campus
Jan 3, 2023
Prostate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIC Prostate Cancer AJCC
Recruiting
- Prostate Adenocarcinoma
- +7 more
- High-Dose Rate Brachytherapy
- Stereotactic Body Radiation Therapy
-
Los Angeles, CaliforniaUniversity of California at Los Angeles / Jonsson Comprehensive
Oct 13, 2022
Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Istanbul (Performing cognitive prostate biopsy with a
Recruiting
- Prostate Cancer
- +4 more
- Performing cognitive prostate biopsy with a radiologist's guidance with map
- Performing cognitive prostate biopsy without a radiologist's guidance with map
-
Istanbul, TurkeyMarmara University, School of Medicine, Department of Urology
Jun 5, 2023
Prostate Adenocarcinoma Trial in Tucson (F-18 fluciclovine-PET/CT scan)
Completed
- Prostate Adenocarcinoma
- F-18 fluciclovine-PET/CT scan
-
Tucson, ArizonaUniversity of Arizona
Aug 12, 2022
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Olaparib)
Recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 23, 2022
Prostatic Tumors, Prostate Cancer, Prostate Adenocarcinoma Trial run by the National Cancer Institute (NCI) (18F-DCFPyL,
Not yet recruiting
- Prostatic Neoplasms
- +2 more
- 18F-DCFPyL
- Stereotactic Body Radiation Therapy
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide
Not yet recruiting
- Prostate Adenocarcinoma
- +2 more
- Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
- Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 4, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +6 more
-
San Francisco, California
- +1 more
Sep 20, 2022
Prostate Adenocarcinoma Trial in United States (procedure, drug, dietary supplement)
Not yet recruiting
- Prostate Adenocarcinoma
- Biopsy
- +3 more
-
Los Angeles, California
- +4 more
Sep 7, 2023
Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester
Active, not recruiting
- Metastatic Prostate Adenocarcinoma
- +6 more
- Intensity-Modulated Radiation Therapy
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Prostate Cancer, Prostate Adenocarcinoma, Prostate Tumor Trial (other, radiation, procedure)
Not yet recruiting
- Prostate Cancer
- +2 more
- Risk Map Decision Support System (DSS).
- +2 more
- (no location specified)
Jan 25, 2023
Prostate Adenocarcinoma, Localized Prostate Carcinoma Trial in San Francisco (High Dose Rate Monotherapy)
Not yet recruiting
- Prostate Adenocarcinoma
- Localized Prostate Carcinoma
- High Dose Rate Monotherapy
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 27, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial in Columbia (Ga-68-PSMA-11)
Terminated
- Prostate Cancer
- Prostate Adenocarcinoma
-
Columbia, MissouriTruman VA Hospital
Feb 15, 2023
Prostate Adenocarcinoma, Prostate Cancer Trial (Transvesical Single Port Robotic Partial Prostatectomy, High-intensity focused
Not yet recruiting
- Prostate Adenocarcinoma
- Prostate Cancer
- Transvesical Single Port Robotic Partial Prostatectomy
- High-intensity focused ultrasound (HIFU)
- (no location specified)
Nov 3, 2022
Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Montreal (131I-PSMA-1095 Radioligand Therapy (RLT))
Active, not recruiting
- Prostate Cancer
- +5 more
- 131I-PSMA-1095 Radioligand Therapy (RLT)
-
Montreal, Quebec, CanadaStephan Probst
Oct 24, 2022
Prostate Disease, Malignancy, Benign Prostatic Hyperplasia Trial in Boston (Self-Administered Nitrous Oxide, Oxygen)
Completed
- Prostate Disease
- +6 more
- Self-Administered Nitrous Oxide
- Oxygen
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Mar 25, 2023